Stave - Saxagliptin Trial To Assess Vascular Endpoints In Diabetes Mellitus Trademark Details
Word Mark | Stave - Saxagliptin Trial to Assess Vascular Endpoints in Diabetes Mellitus |
---|---|
Status | Dead 601 — Abandoned - Express |
Current Owner
Serial Number | 77813061 |
---|---|
Status Date | Monday, April 12, 2010 |
Filing Date | Monday, April 12, 2010 |
Attorney | Tanya Fickenscher Leonard |
Correspondent
Tanya Fickenscher Leonard
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154
Case File Statements
Goods & Services | Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use |
---|---|
Pseudo Mark | Stave - Saxagliptin Trial to Assess Vascular End Points in Diabetes Mellitus |
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Thursday, September 3, 2009 |
Primary Code | 042 |
Trademark Timeline
-
Aug 26 2009Trademark application filed with USPTO
-
Sep 01 2009New Application Entered In Tram
-
Sep 03 2009New Application Office Supplied Data Entered In Tram
-
Sep 04 2009Notice of Pseudo Mark Mailed
-
Nov 05 2009Non-Final Action Written
-
Nov 05 2009Assigned To Examiner
-
Nov 06 2009Non-Final Action Mailed
-
Dec 28 2009Attorney Revoked And/or Appointed
-
Dec 28 2009Teas Revoke/appoint Attorney Received
-
Apr 09 2010Teas Express Abandonment Received
-
Apr 12 2010Abandonment Notice Mailed - Express Abandonment
-
Apr 12 2010Abandonment - Express Mailed